Cell population was considered
homogeneous and conventional cell-based assays provide average responses
from a population of many thousands of cells. Hence, it is difficult to
understand the complex nature of the cells. The results obtained from
such analyses represent an amalgam. In order to better understand the
function and variation of cells, researchers need to study a single cell
to develop better drug formulation to prevent infectious diseases. Rare
cell events, small changes between individual cells, could hold the key
to the unresolved questions in cancer, stem cell biology, immunology,
developmental biology and neurology, and facilitate therapeutic decision
making in precision medicine.
The number of infectious disease outbreaks across the world has
increased steadily. The variety of outbreak causing diseases also went
up. According to the Journal of the Royal Society Interface 2014, about
10,643 infectious disease outbreaks were reported across the world in
2014. Global Health Estimates that around 2.74 million death were
attributed to respiratory diseases such as pneumonia and influenza in
2015. High incidence of infectious diseases is projected to drive demand
for new drug formulation to treat or control these diseases. This in
turn is anticipated to boost demand for single cell isolation systems
market.
The global single cell isolation systems market can be segmented
based on product, application, end-user, and region. In terms of
product, the global single cell isolation systems market can be
classified into flow cytometry systems, microfluidic systems, laser
microdissection systems, and others. The flow cytometry systems segment
is projected to account for significant share of the single cell
isolation systems market during the forecast period. Flow cytometry is a
tool that enables to easily cope with the minute amounts of biological
materials. Moreover, flow cytometry helps to analyze the heterogeneous
population of cells within a few minutes. Based on application, the
global single cell isolation systems market can be categorized into drug
discovery, life science research, and others. The drug discovery
segment is anticipated to account for large market share owing to wide
usage of these systems in the development of new formulation of drugs to
treat various diseases. In terms of end-user, the single cell isolation
systems market can be divided into research institutes and
pharmaceutical & biotechnologies companies. The pharmaceutical &
biotechnologies companies segment is expected to expand at a high CAGR
during the forecast period owing to high research and development
activity to discover new drug formulation to treat diseases.
In terms of region, the global single cell isolation systems market
can be segmented into North America, Europe, Asia Pacific, Latin
America, and Middle East & Africa. North America dominated the
global market in 2017. The region is projected to account for
significant share of the global single cell isolation systems market due
to research and development activity to develop new drugs. Asia Pacific
is anticipated to account for substantial share of the global single
cell isolation systems market in terms of revenue during the forecast
period due to the emergence of the region as a major manufacturing hub
and rise in expertise and academic excellence.
Major players operating in the global
single cell isolation systems market include BD, Bio-Rad Laboratories,
Inc., Miltenyi Biotec, 10x Genomics, STEMCELL Technologies, Inc., Thermo
Fisher Scientific, GE Healthcare, and Carl Zeiss AG.
No comments:
Post a Comment